Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bile acid mixture refers to a pharmaceutical or supplement formulation that contains two or more individual bile acids in defined or variable proportions, often used as *bile acid replacement therapy* for bile acid synthesis disorders or as digestive aids. Bile acids (including cholic acid, chenodeoxycholic acid, deoxycholic acid, ursodeoxycholic acid, and others) are endogenous steroid acids produced by the liver and play a critical role in fat digestion and absorption, cholesterol homeostasis, and signaling via activation of specific receptors such as the farnesoid X receptor (FXR). In medical use, bile acid mixtures aim to restore physiologic bile acid pools in patients with genetic or acquired deficiencies, thereby improving fat and fat-soluble vitamin absorption and preventing liver injury due to accumulation of toxic bile acid intermediates. Mechanistically, bile acids act as detergents to emulsify dietary lipids, and as hormone-like signaling molecules regulating metabolic pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bile acid mixture.